Education
About Us
Working with TipRanks
Follow Us
Windtree Therapeutics Inc (WINT)
:WINT
RESEARCH TOOLSreports
Total Valuation
Windtree Therapeutics has a market cap or net worth of $931.00K. The enterprise value is $12.94M.
Market Cap$931.00K
Enterprise Value$12.94M
Share Statistics
Windtree Therapeutics has 700.00K shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding700.00K
Owened by Insiders3.73%
Owened by Instutions<0.01%
Financial Efficiency
Windtree Therapeutics’s return on equity (ROE) is -5.98 and return on invested capital (ROIC) is -60.32%.
Return on Equity (ROE)-598.38%
Return on Assets (ROA)-62.61%
Return on Invested Capital (ROIC)-60.32%
Return on Capital Employed (ROCE)-61.74%
Revenue Per Employee$0
Profits Per Employee-$485,400
Employee Count20
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Windtree Therapeutics is -0.41. Windtree Therapeutics’s PEG ratio is <0.01.
PE Ratio-0.41
PS Ratio0.00
PB Ratio2.45
Price to Fair Value2.45
Price to FCF-0.62
Price to Operating Cash Flow-0.62
PEG Ratio<0.01
Income Statement
In the last 12 months, Windtree Therapeutics had revenue of $0.00 and earned -$9.71M in profits. Earnings per share was -$20.34.
Revenue$0.00
Gross Profit-$67.00K
Operating Income-$25.56M
Pretax Income-$9.64M
Net Income-$9.71M
EBITDA-9.26M
Earnings Per Share (EPS)-20.34
Cash Flow
In the last 12 months, operating cash flow was -$15.28M and capital expenditures -$12.00K, giving a free cash flow of -$15.30M billion.
Operating Cash Flow-$15.28M
Free Cash Flow-$15.30M
Free Cash Flow per Share-$21.85
Dividends & Yields
Windtree Therapeutics pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-162.15%
Earnings Yield-244.58%
Stock Price Statistics
Beta1.68
52-Week Price Change-99.65%
50-Day Moving Average3.27
200-Day Moving Average111.14
Relative Strength Index (RSI)26.30
Average Volume (3m)5.61M
Important Dates
Windtree Therapeutics upcoming earnings date is May 14, 2025, TBA.
Last Earnings DateApr 2, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Windtree Therapeutics as a current ratio of 1.35, with Debt / Equity ratio of 4.96
Current Ratio1.35
Quick Ratio1.35
Debt to Market Cap1.84
Net Debt to EBITDA-0.62
Interest Coverage Ratio-350.78
Taxes
In the past 12 months, Windtree Therapeutics has paid $49.19K in taxes.
Income Tax$49.19K
Effective Tax Rate0.00%
Enterprise Valuation
Windtree Therapeutics EV to EBITDA ratio is -1.03, with an EV/FCF ratio of -1.55.
EV to Sales0.00
EV to EBITDA-1.03
EV to Free Cash Flow-1.55
EV to Operating Cash Flow-1.55
Balance Sheet
Windtree Therapeutics has $2.30M in cash and marketable securities with $2.01M in debt, giving a net cash position of -$287.00K billion.
Cash & Marketable Securities$2.30M
Total Debt$2.01M
Net Cash-$287.00K
Net Cash Per Share-$0.41
Tangible Book Value Per Share-$99.36
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Windtree Therapeutics is , which is 11.43% higher than the current price. The consensus rating is Hold
Price Target
Price Target Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast94.78%